Serum lncRNAs, NBAT‐1, and FOXCUT signature in hepatocellular carcinoma developed on top of chronic hepatitis C

Faculty Medicine Year: 2022
Type of Publication: ZU Hosted Pages:
Authors:
Journal: Molecular carcinogenesis Wiley Volume:
Keywords : Serum lncRNAs, NBAT‐1, , FOXCUT signature in hepatocellular    
Abstract:
Background: Hepatocellular Carcinoma (HCC) is a universal health problem responsible for 8.2% of all cancer deaths. Numerous risk factors were documented to be contributed to HCC development with viral hepatitis C ranking as the major predisposing factor in Egypt. The presence of a detectable amount of long noncoding RNAs (lncRNAs) in the circulation is linked to the development and spread of tumors. LncRNAs NBAT‐1 and FOXCUT expression levels were used as genetic markers for the detection of gastrointestinal tract cancers. We hypothesized that serum expression levels of NBAT‐1 and FOXCUT are new biomarkers for HCC that are related to laboratory and pathological markers. Patients and Methods: This study included 165 hepatitis C virus (HCV)‐related HCC Egyptian patients, 180 HCV‐infected noncancer patients, and 180 healthy controls, the serum expression levels of NBAT‐1 and FOXCUT were measured by using quantitative real‐time polymerase chain reaction. Results: This study's results include that medians (inter‐quartile range [IQRs]) of NBAT‐1 in HCC and HCV patients were (1.9 [0.87−4.94], 10.01 [7.34−13.29] respectively) which exhibited significantly higher expression than controls, while the medians (IQRs) of FOXCUT in HCC and HCV patients were (0.15 [0.04−0.52], 6.42 [2.49−10.10], respectively) that exhibited significantly lower expression than controls regarding HCC patients but significantly higher expression than controls regarding HCV patients. In comparing serum fold changes of NBAT‐1 and FOXCUT between HCC patients and HCV patients; we obtained significantly higher levels of target genes in HCV patients (p < 0.001) than in HCC patients. Also, a positive correlation was detected between NBAT‐1 and FOXCUT in HCC group (r = 0.262, p = 0.001) and in HCV group (r = 0.937, p < 0.001). Higher serum NBAT‐1 and FOXCUT were significantly associated with better clinical and laboratory data of the disease. Multivariate regression analysis showed that FOXCUT was an independent predictor for HCC among HCV patients (p < 0.001)
   
     
 
       

Author Related Publications

  • 2251, "Pleurodesis Using Bleomycin Ampoules, Doxycycline Capsules, and Povidone Iodine Solution in Patients with Malignant Pleural Effusion in Zagazig University Hospitals", Zagazig University, Faculty of Medicine, 2022 More
  • 2251, "Outcome of docetaxel in treatment of metastatic hormone-sensitive prostate cancer and correlation with hemoglobin, albumin, lymphocyte and platelets score", Termedia Publishing House Ltd., 2022 More
  • 2251, "The incidence and clinical characteristics of pulmonary embolism in oncologic patients", Springer, 2022 More
  • 2251, "Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer", Termedia Publishing House Ltd., 2023 More
  • 2251, "Clinical value of 18F-PSMA-1007 PET/MRI in primary staging of patients with intermediate- to high-risk prostate cancer", Oxford University Press, 2024 More

Department Related Publications

  • Rasha Mohamed Mostafa Hagag, "Impact of Prognostic Nutritional Index and Systemic Immune-Inflammation Index on the Clinical Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib", Zagazig University Medical Journal, 2022 More
  • Rasha Mohamed Mostafa Hagag, "Diagnosis of Sepsis among Adult Patients with AML Using Scd14", Ain Shams University, Faculty of Medicine, Pan Arab League of Continuous Medical Education, 2021 More
  • Rasha Mohamed Mostafa Hagag, "Prognostic Impact of microRNAs (miR-155, miR-10a, let-7a) on the Outcome of Adult Patients with Acute Myeloid Leukemia.", Zagazig University, Faculty of Medicine, 2021 More
  • Shereen Mostafa Saleh Elshorbagy, "Prognostic Roles of ZNF703 and SMAD4 Expression in Patients with Papillary Thyroid Cancer and Association with Nodal Metastasis", pubmed, 2022 More
  • Shereen Mostafa Saleh Elshorbagy, "RNA-binding proteins RBM-HuR, RBM3 and PODXL expression in urothelial carcinoma of the urinary bladder. Prognostic and clinical implications", PMID: 35079236, 2022 More
Tweet